Further, excessive TGF-β signaling was detected in mouse models of Marfan syndrome, and a TGF-β neutralizing antibody, as well as losartan, partially reversed vascular manifestations of Marfan’s syndrome (62). The gene discussed is TGFB1; the disease is Marfan syndrome.